Zinc(II) ion mediates tamoxifen-induced autophagy and cell death in MCF-7 breast cancer cell line. 2010

Jung Jin Hwang, and Ha Na Kim, and Jean Kim, and Dong-Hyung Cho, and Mi Joung Kim, and Yong-Sook Kim, and Yunha Kim, and Sung-Jin Park, and Jae-Young Koh
Institute for Innovative Cancer Research, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, 138-736, Korea.

Treatment of MCF-7 cells with tamoxifen induced vacuole formation and cell death. Levels of the autophagy marker, microtubule-associated protein light chain 3 (LC3)-II also increased, and GFP-LC3 accumulated in and around vacuoles in MCF-7 cells exposed to tamoxifen, indicating that autophagy is involved in tamoxifen-induced changes. Live-cell confocal microscopy with FluoZin-3 staining and transmission electron microscopy with autometallographic staining revealed that labile zinc(II) ion (Zn(2+)) accumulated in most acidic LC3(+) autophagic vacuoles (AVs). Chelation of Zn(2+) with N,N,N',N'-tetrakis (2-pyridylmethyl) ethylenediamine (TPEN) blocked the increase in phospho-Erk and LC3-II levels, and attenuated AV formation and cell death. Conversely, the addition of ZnCl(2) markedly potentiated tamoxifen-induced extracellular signal-regulated kinase (Erk) activation, autophagy and cell death, indicating that Zn(2+) has an important role in these events. Tamoxifen-induced death was accompanied by increased oxidative stress and lysosomal membrane permeabilization (LMP) represented as release of lysosomal cathepsins into cytosol. Treatment with the antioxidant N-acetyl-L-cysteine (NAC) blunted the increase in Zn(2+) levels and reduced LC3-II conversion, cathepsin D release and cell death induced by tamoxifen. And cathepsin inhibitors attenuated cell death, indicating that LMP contributes to tamoxifen-induced cell death. Moreover, TPEN blocked tamoxifen-induced cathepsin D release and increase in oxidative stress. The present results indicate that Zn(2+) contributes to tamoxifen-induced autophagic cell death via increase in oxidative stress and induction of LMP.

UI MeSH Term Description Entries
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D011083 Polycyclic Compounds Compounds which contain two or more rings in their structure. Compounds, Polycyclic
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002614 Chelating Agents Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. Chelating Agent,Chelator,Complexons,Metal Antagonists,Chelators,Metal Chelating Agents,Agent, Chelating,Agents, Chelating,Agents, Metal Chelating,Antagonists, Metal,Chelating Agents, Metal
D005029 Ethylenediamines Derivatives of ethylenediamine (the structural formula NH2CH2CH2NH2).
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001343 Autophagy The segregation and degradation of various cytoplasmic constituents via engulfment by MULTIVESICULAR BODIES; VACUOLES; or AUTOPHAGOSOMES and their digestion by LYSOSOMES. It plays an important role in BIOLOGICAL METAMORPHOSIS and in the removal of bone by OSTEOCLASTS. Defective autophagy is associated with various diseases, including NEURODEGENERATIVE DISEASES and cancer. Autophagocytosis,ER-Phagy,Lipophagy,Nucleophagy,Reticulophagy,Ribophagy,Autophagy, Cellular,Cellular Autophagy,ER Phagy
D013629 Tamoxifen One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. ICI-46,474,ICI-46474,ICI-47699,Nolvadex,Novaldex,Soltamox,Tamoxifen Citrate,Tomaxithen,Zitazonium,Citrate, Tamoxifen,ICI 46,474,ICI 46474,ICI 47699,ICI46,474,ICI46474,ICI47699

Related Publications

Jung Jin Hwang, and Ha Na Kim, and Jean Kim, and Dong-Hyung Cho, and Mi Joung Kim, and Yong-Sook Kim, and Yunha Kim, and Sung-Jin Park, and Jae-Young Koh
November 2019, Breast cancer (Tokyo, Japan),
Jung Jin Hwang, and Ha Na Kim, and Jean Kim, and Dong-Hyung Cho, and Mi Joung Kim, and Yong-Sook Kim, and Yunha Kim, and Sung-Jin Park, and Jae-Young Koh
February 2014, Journal of cellular and molecular medicine,
Jung Jin Hwang, and Ha Na Kim, and Jean Kim, and Dong-Hyung Cho, and Mi Joung Kim, and Yong-Sook Kim, and Yunha Kim, and Sung-Jin Park, and Jae-Young Koh
November 2014, Chemico-biological interactions,
Jung Jin Hwang, and Ha Na Kim, and Jean Kim, and Dong-Hyung Cho, and Mi Joung Kim, and Yong-Sook Kim, and Yunha Kim, and Sung-Jin Park, and Jae-Young Koh
December 2005, Apoptosis : an international journal on programmed cell death,
Jung Jin Hwang, and Ha Na Kim, and Jean Kim, and Dong-Hyung Cho, and Mi Joung Kim, and Yong-Sook Kim, and Yunha Kim, and Sung-Jin Park, and Jae-Young Koh
June 2004, Life sciences,
Jung Jin Hwang, and Ha Na Kim, and Jean Kim, and Dong-Hyung Cho, and Mi Joung Kim, and Yong-Sook Kim, and Yunha Kim, and Sung-Jin Park, and Jae-Young Koh
January 2013, Molecules (Basel, Switzerland),
Jung Jin Hwang, and Ha Na Kim, and Jean Kim, and Dong-Hyung Cho, and Mi Joung Kim, and Yong-Sook Kim, and Yunha Kim, and Sung-Jin Park, and Jae-Young Koh
June 1992, In vitro cellular & developmental biology : journal of the Tissue Culture Association,
Jung Jin Hwang, and Ha Na Kim, and Jean Kim, and Dong-Hyung Cho, and Mi Joung Kim, and Yong-Sook Kim, and Yunha Kim, and Sung-Jin Park, and Jae-Young Koh
October 2012, Investigational new drugs,
Jung Jin Hwang, and Ha Na Kim, and Jean Kim, and Dong-Hyung Cho, and Mi Joung Kim, and Yong-Sook Kim, and Yunha Kim, and Sung-Jin Park, and Jae-Young Koh
January 2023, Archives of medical science : AMS,
Jung Jin Hwang, and Ha Na Kim, and Jean Kim, and Dong-Hyung Cho, and Mi Joung Kim, and Yong-Sook Kim, and Yunha Kim, and Sung-Jin Park, and Jae-Young Koh
February 2015, Scientific reports,
Copied contents to your clipboard!